Keyphrases
Antiarrhythmic Therapy
100%
Cost-effectiveness
100%
Supraventricular Tachycardia
100%
Therapy Initiation
100%
Event Rate
60%
Hospitalization
40%
Structural Heart Disease
40%
Lifesaving
40%
Confidence Interval
20%
Ventricular Arrhythmia
20%
Clinical Scenarios
20%
MEDLINE
20%
Metaanalysis
20%
Older Patients
20%
Cardiac Arrest
20%
Arrhythmic Risk
20%
Life Expectancy
20%
Outpatient Therapy
20%
40 Years Old
20%
Syncope
20%
Drug Trials
20%
Decision Analysis
20%
Normal Life Expectancy
20%
Cost-effectiveness Ratio
20%
Unexplained Death
20%
Therapy Models
20%
Inpatient Therapy
20%
Cardiac Sudden Death
20%
Clinical Decision Model
20%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
Supraventricular Tachycardia
100%
Heart Disease
50%
Life Expectancy
50%
Sample Size
25%
Meta Analysis
25%
Confidence Interval
25%
Outpatient
25%
Sudden Cardiac Death
25%
Faintness
25%
Outpatient Care
25%
Heart Ventricle Arrhythmia
25%
Drug Screening
25%
Pharmacology, Toxicology and Pharmaceutical Science
Supraventricular Tachycardia
100%
Antiarrhythmic Drug
100%
Heart Disease
50%
Life Expectancy
50%
Heart Ventricle Arrhythmia
25%
Drug Screening
25%
Faintness
25%
Sudden Cardiac Death
25%